OMNI CORNEAL CROSS LINKING
• Variable settings from 3 mW to 45 mW with simultaneous radiation time adjustment
• Continuous, pulsed and LASIK radiation mode
• Self calibrating and self adjusting
• Eye tracking
• Integrated pachymeter optional
Corneal Cross Linking is a treatment whose goal is to strengthen the corneal stromal tissue through the formation of new chemical bonds between stromal collagen fibrils.
Cross Linking is the only effective treatment to stop progressive keratonconus as well as related ectatic disorders (such as PMD and iatrogenic ectasia) and has a regularization effect on corneal topography.
The basis for the currently employed corneal collagen cross-linking techniques were developed in Europe by researchers at the University of Dresden in the late 1990's by Prof. Theo Seiler, MD, PhD and Prof. Eberhard Spoerl. Human studies of UV- induced corneal crosslinking began in 2003 in Dresden and early results were promising. The initial pilot study enrolled 16 patients with rapidly progressing keratoconus and all of the patients stopped progressing after treatment.
Additionally, 70% had flattening of their steep anterior corneal curvatures (decreases in average and maximum keratometric values), and 65% had an improvement in visual acuity. There were no reported complications. It received CE mark in 2006.
Today our Cross Linking systems are in clinical use in more than 100 countries around the world.
The OMNI Cross Linking System was designed with a special focus on effectiveness, safety and user friendliness incorporating the latest clinical experiences.
OMNI Cross Linking System enables the user to fine tune the required energy from 3 mW to 45 mW per cm2 in 1 mW intervals with automatic time adjustment. Furthermore it allows pulsed radiation in connection with the latest experience in treating infectious keratitis.
The system has an integrated infrared camera for eye tracking which also ensures proper distance. The tracking area as well as the threshold can be individually set. If the eye moves outside the parameters, the system will pause. It includes a built in calibration verification to continuously measure emitted light intensity.
An integrated pachymeter is optionally available with automatic Riboflavin selection recommendation.
For documentation, the patient data and treatment settings can easily be exported in .pdf format via Wi-Fi or BlueTooth or can be printed directly on an external printer.
A 7 inch color touch screen display shows all relevant information: Eye monitoring, treatment settings and remaining treatment time.
A large number of major clinical studies has proven the effectiveness of Cross Linking and the lack of serious side effects. More than 85% of eyes treated with Cross Linking showed a significant increase of BVCA. Six months after the procedure, cylinder was reduced in the majority of patients.
For more details, Click Here to visit our website.